Combined the surgery, radiation, and chemotherapy for predicting overall survival in patients with gastroenteropancreatic neuroendocrine tumors.

ABSTRACT:

Background

Over the last few decades, the annual global incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has steadily increased. Because of the complex and inconsistent treatment of GEP-NETs, the prognosis of patients with GEP-NETs is still difficult to assess. The study aimed to construct and validate the nomograms included treatment data for prediction overall survival (OS) in GEP-NETs patients.

Methods

GEP-NETs patients determined from the Surveillance, Epidemiology, and End Results (SEER)-13 registry database (1992-2018) and with additional treatment data from the SEER-18 registry database (1975-2016). In order to select independent prognostic factors that contribute significantly to patient survival and can be included in the nomogram, multivariate C

SUBMITTER: Wu Z 

PROVIDER: S-EPMC11020034 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature